Rxsight Inc
Ownership
Ownership Structure
Who owns Rxsight Inc (RXST)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 81.0% of the shares are freely tradable; institutional investors hold 99.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 7.66 | 3,187,092 | +17.8 | 03/31/2026 |
| Millennium Management LLC | 7.29 | 3,030,287 | +47.1 | 06/30/2026 |
| No Street GP LP | 4.94 | 2,055,000 | +2.8 | 06/30/2026 |
| Nomura Holdings Inc | 4.81 | 2,000,060 | +0.0 | 06/30/2026 |
| D. E. Shaw & Co LP | 4.77 | 1,985,215 | +1.3 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.07 | 1,692,935 | +0.0 | 03/31/2026 |
| Bank of America Corp | 2.91 | 1,210,039 | +30.3 | 03/31/2026 |
| Federated Hermes Inc | 2.89 | 1,201,195 | +11.1 | 06/30/2026 |
| Two Sigma Investments LLC | 2.76 | 1,147,048 | -11.8 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.95 | 1,227,155 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Weinberg Eric | See remarks | 235,516 | 1,106,925 $ | Sep 15, 2026 | direct |
| Goldshleger Ilya | Chief Operating Officer | 81,509 | 383,092 $ | Sep 2, 2026 | direct |
| Kurtz Ronald M MD | Chief Medical Officer | 71,775 | 337,343 $ | Sep 2, 2026 | direct |
| Wilterding Mark | Chief Financial Officer | 25,049 | 117,730 $ | Sep 2, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Weinberg Eric | See remarks | Other | 35,168 | 4.34 | 152,629 |
| Sep 2, 2026 | Kurtz Ronald M MD | Chief Medical Officer | Sell | 5,100 | 6.96 | 35,496 |
| Sep 2, 2026 | Wilterding Mark | Chief Financial Officer | Sell | 7,765 | 6.96 | 54,044 |
| Sep 2, 2026 | Goldshleger Ilya | Chief Operating Officer | Sell | 2,041 | 6.96 | 14,205 |
| Sep 2, 2026 | Weinberg Eric | See remarks | Sell | 2,041 | 6.96 | 14,205 |
| Aug 31, 2026 | Kurtz Ronald M MD | Chief Medical Officer | Other | 13,425 | – | – |
| Aug 31, 2026 | Wilterding Mark | Chief Financial Officer | Other | 20,441 | – | – |
| Aug 31, 2026 | Goldshleger Ilya | Chief Operating Officer | Other | 5,370 | – | – |
| Aug 31, 2026 | Weinberg Eric | See remarks | Other | 5,370 | – | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.